CEVA Defends Executive Compensation Amidst ISS "Say-on-Pay" Opposition
Summary
CEVA issued supplemental proxy materials to defend its executive compensation plan, specifically the extension of PSU performance periods, after proxy advisory firm ISS recommended against the "say-on-pay" proposal.
Key Events
-
Proxy Advisor Opposition
Proxy advisory firm ISS recommended against Proposal 2, the advisory "say-on-pay" proposal, citing the extension of performance periods for certain long-term Performance Share Unit (PSU) awards.
-
PSU Performance Period Extended
The performance period for PSU awards granted in February 2023 to Section 16 officers was extended by two years, from December 2025 to December 2027.
-
Company Rationale Provided
CEVA's Board justified the extension by citing long development and customer adoption cycles in semiconductor IP and Edge AI, the need for executive retention, and avoiding the cost of new replacement awards.
-
Ahead of Annual Meeting
This supplemental information is provided in connection with the upcoming Annual Meeting of Stockholders on June 2, 2026, where shareholders will vote on the compensation proposal.
Analysis
This filing provides supplemental information to CEVA's definitive proxy statement, directly addressing the negative recommendation from proxy advisory firm ISS regarding the "say-on-pay" proposal. ISS opposes the extension of performance periods for executive Performance Share Unit (PSU) awards. The company's detailed rationale for the extension, citing long development cycles and retention needs, highlights a potential point of contention with shareholders ahead of the June 2nd annual meeting. A lower "say-on-pay" vote could signal shareholder dissatisfaction with executive compensation practices, even as the company's stock trades near its 52-week high following strong Q1 results.
At the time of this filing, CEVA was trading at $40.56 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $17.02 to $40.53. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.